Clinical Studies

 

JXT5® Clinical Study References

  1. Poole et al. (2009). Effects of TESTOSURGE® Supplementation on strength, body composition and hormonal profiles during an 8-week resistance training program. JISSN. 6(Suppl1):12.
  2. Wilbon C, et al. (2010). Effects of a purported aromatase and 5-alpha reductase inhibitor on hormone profiles in college-age men. IJSNEM. 20(6):457-465.
  3. Mokashi M, et al. (2014). Effects of glycosides based fenugreek seed extract on serum testosterone levels of healthy sedentary male subjects: an exploratory double-blind, placebo-controlled, crossover study. Asian J of Pharmaceutical and Clinical Research. 7(2):177-181.
  4. Biswas TK, et al. (2009). Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia 42: 48-56.
  5. Pandit S. (2015). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia 48: 570-575.
  6. Reyes-Izquierdo T, et al. (2011). Short-term intake of Calcium Fructoborate improves WOMAC and McGill  scores and beneficially modulates biomarkers associated with knee osteoarthritis: A pilot clinical double-blind placebo-controlled study. American Journal of Biomedical Science. ISSN: 1937-9080.
  7. Scorei R, et al. (2011). A double-blind, placebo-controlled pilot study to evaluate the effect of Calcium Fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res. 144:253-263.
  8. Reyes-Izquierdo T, et al. (2014). Short-term efficacy of a combination of Glucosamine and Chondroitin Sulfate compared to a combination of Glucosamine, Chondroitin Sulfate and Calcium Fructoborate (CFB) on improvement of knee discomfort conditions in healthy subjects. A comparative, double-blind, placebo controlled acute clinical study. Jour of Aging Research & Clinical Practice. 3(4): 223-228.
  9. Pietrzkowski Z, et al. (2014). Short-term efficacy of Calcium Fructoborate on subjects with knee discomfort: a comparative double-blind, placebo-controlled clinical study. Clinical Interventions in Aging. 9: 895-899.


 

Pyro Stim 7® Clinical Study References

  1. Snitker S, et al. (2009). Effects of capsinoid treatment on fatness and energy metabolism in humans: Possible pharmacogenetic implications. Am J Clin Nutr. 89(1): 45-50.
  2. Leung, FW. (2008). Capsaicin-sensitive intestinal mucosal afferent mechanism and body fat distribution. Life Sci. 83 (1-2): 1-5
  3. Lejeune MP, et al. (2003) Effects of capsaicin on substrate oxidation and weight maintenance after modest body-weight loss in human subjects. Br J Nutr. 90(3): 651-59.
  4. Reinbach H, et al. (2009). Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. Clin Nut. (3): 260-5.
  5. Leung, FW. (2014). Capsaicin as an anti-obesity drug. Prog Drug Res. 68:171-9.
  6. Janssens PL, et al. (2014). Capsaicin increases sensation of fullness in energy balance, and decreases desire to eat after dinner in negative energy balance. Appetite. 77:44-49.
  7. Preuss H, et al. (2002). Citrus aurantium as a thermogenic, weight reduction replacement for ephedra: An overview. Journal of Medicine. 331(1-4):247-264.
  8. Gougeon R, et al. (2005). Increase in the thermic effect of food in women by adrenergic amines extracted from Citrus aurantium. Obesity Research. 13(7); 1187-1194.
  9. Pathak B, et al. (2005). Thermic effect of Citrus aurantium in obese subjects. Obesity Research.
  10. Hedrei P, et al. (2005). Thermogenic effect of beta sympathicomimetic compounds extracted from Citrus aurantium. Obesity Research.